Development of vegetable protein hydrolysates and vegetable components for optimal growth of mammelian cell culture media. This lowers the risk of pharmaceutical products becoming contaminated with viruses, b.S.E., Etc.
Development of a wide format 536 inch) colour scanner module, which may be combined with a colour or black and white printer module to form a hybrid copier/printer system.
Acceleration and diversification of flavour formation in semi-hard cheeses, by controlling amino-acid catabolism with lactic acid bacteria (lab).
The mission of "euroagri+" is to assist the application of innovation and technologies within the agriculture, food and feed sectors in order to strengthen european competitiveness.
Supporting the development of products and systems exploiting micro- and nano-technologies, including enabling technologies, manufacturing and equipment for all application domains, by capitalizing on the success of eurimus.
Recycled paper industry faces increasing problems with fibre quality. Research will be executed on the possibilities of using specific fibre-modifying enzymes to improve pulp and paper properties. Action of the enzymes will be studied.
This umbrella aims at the creation of a european-wide platform to combine r & d capabilities and expertise in order to generate projects in the area of fish breeding.
There are two main challenges: 1. To become sustainable by reducing resource consumption, managing transport and utility networks in a sustainable way, reducing environmental and man-made impacts, improving safety and security and protecting cultural heritage; 2. To become a demand-driven sector.
Zf-implants(r), which is based on patented platform technology, will be developed as a tool to enhance eel reproduction. The implants incur low stress and result in natural hormone levels. The dutch-danish consortium aims to obtain an optimal protocol for production of viable eggs and larvae.
The project deals with the combination of a novel viral vector technology with a proprietary dendritic cell vaccine delivery technology to develop immuno-therapies to treat type 1 diabetes, house dust mite allergy and breast cancer; all major immunity-associated diseases.